MedPath

A randomized controlled study on treating chronic pharyngitis by Lianquan acupoint injection of vitamin B12 and dexamethasone

Phase 1
Recruiting
Conditions
chronic pharyngitis
Registration Number
ITMCTR2100004844
Lead Sponsor
Chengdu Renpin Ear, Nose and Throat Specialist Hospital
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Recruiting
Sex
All
Target Recruitment
Not specified
Inclusion Criteria

1. Meet the diagnostic criteria for chronic pharyngitis in Practical Otorhinolaryngology;
2. Patients between the ages of 18-65 who are diagnosed with chronic pharyngitis during acute exacerbation;
3. No treatment for pharyngitis was performed within 4 weeks before the enrollment of the study;
4. The course of the disease was 3 months to 10 years;
5. The informed consent was signed.

Exclusion Criteria

1. Suffer from cancer or other physical diseases and specific pharyngitis (such as ulcerative membranous angina, viral pharyngitis, scarlet fever pharyngitis, blood disease pharyngitis, such as infectious mononucleosis, agranulocytosis, etc.) And pharyngeal inflammation caused by infectious diseases;
2. Patients with serious basic diseases such as diabetes and coronary heart disease; patients who do not receive external treatment of Chinese medicine; have had acupoint injection therapy within 7 days;
3. Unable to follow up; patients with excessive anxiety, high expectations for treatment, pregnant women and breastfeeding patients.

Study & Design

Study Type
Interventional study
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath